Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$524M |
| 2 |
Peloton Interactive
PTON
|
+$465M |
| 3 |
Amazon
AMZN
|
+$312M |
| 4 |
WORK
Slack Technologies, Inc.
WORK
|
+$290M |
| 5 |
Snap
SNAP
|
+$262M |
Top Sells
| 1 |
Zoom
ZM
|
+$965M |
| 2 |
Pinduoduo
PDD
|
+$805M |
| 3 |
AbbVie
ABBV
|
+$794M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$757M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$750M |
Sector Composition
| 1 | Healthcare | 20.82% |
| 2 | Technology | 16.68% |
| 3 | Consumer Discretionary | 11.18% |
| 4 | Communication Services | 10.87% |
| 5 | Consumer Staples | 10.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PFC
676
DELISTED
Premier Financial Corp. Common Stock
PFC
| $23.6M | 0.03% |
1,025,011
-160,531
| -14% | -$3.69M |
|
677
CRISPR Therapeutics
CRSP
$4.71B
| $23.5M | 0.03% |
153,200
-241,500
| -61% | -$37M |
|
678
Atlanta Braves Holdings Series B
BATRK
$2.62B
| $23.4M | 0.03% |
940,219
-31,900
| -3% | -$794K |
|
679
SpartanNash
SPTN
$900M
| $23.4M | 0.03% |
1,342,278
-346,500
| -21% | -$6.03M |
|
680
Towne Bank
TOWN
$2.84B
| $23.3M | 0.03% |
990,642
-171,041
| -15% | -$4.02M |
|
681
Community Health Systems
CYH
$409M
| $23.2M | 0.03% |
3,126,635
+1,457,675
| +87% | +$10.8M |
|
|
BMTC
682
DELISTED
Bryn Mawr Bank Corp
BMTC
| $23.2M | 0.03% |
758,420
-22,400
| -3% | -$685K |
|
683
National Research Corp
NRC
$366M
| $23.2M | 0.03% |
541,984
+4,184
| +0.8% | +$179K |
|
684
ManpowerGroup
MAN
$1.75B
| $23.2M | 0.03% |
256,752
-94,300
| -27% | -$8.5M |
|
|
CTB
685
DELISTED
Cooper Tire & Rubber Co.
CTB
| $23.1M | 0.03% |
571,479
-37,721
| -6% | -$1.53M |
|
686
Alpha and Omega Semiconductor
AOSL
$858M
| $23.1M | 0.03% |
976,800
+164,200
| +20% | +$3.88M |
|
687
10x Genomics
TXG
$1.57B
| $23M | 0.03% |
162,700
-133,400
| -45% | -$18.9M |
|
688
American Homes 4 Rent
AMH
$12.7B
| $23M | 0.02% |
765,529
-6,757
| -0.9% | -$203K |
|
689
Carter's
CRI
$1.04B
| $22.9M | 0.02% |
243,800
+137,000
| +128% | +$12.9M |
|
690
Portland General Electric
POR
$4.63B
| $22.9M | 0.02% |
535,593
-982,135
| -65% | -$42M |
|
691
Huazhu Hotels Group
HTHT
$11.4B
| $22.8M | 0.02% |
507,400
+281,800
| +125% | +$12.7M |
|
692
Ironwood Pharmaceuticals
IRWD
$187M
| $22.8M | 0.02% |
2,005,753
+1,088,000
| +119% | +$12.4M |
|
693
ArcBest
ARCB
$1.61B
| $22.7M | 0.02% |
532,239
+60,300
| +13% | +$2.57M |
|
|
FPRX
694
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $22.7M | 0.02% |
1,334,848
-361,338
| -21% | -$6.15M |
|
695
Eagle Materials
EXP
$7.49B
| $22.7M | 0.02% |
224,000
+72,800
| +48% | +$7.38M |
|
696
PennyMac Financial
PFSI
$6.22B
| $22.7M | 0.02% |
345,600
-118,300
| -26% | -$7.76M |
|
697
Axon Enterprise
AXON
$58.7B
| $22.7M | 0.02% |
184,952
+82,200
| +80% | +$10.1M |
|
698
KRONOS Worldwide
KRO
$721M
| $22.6M | 0.02% |
1,518,500
-62,500
| -4% | -$932K |
|
699
Weis Markets
WMK
$1.73B
| $22.6M | 0.02% |
472,136
-21,575
| -4% | -$1.03M |
|
700
Halozyme
HALO
$8.87B
| $22.6M | 0.02% |
528,129
+429
| +0.1% | +$18.3K |
|